Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,698Revenue $M498Net Margin (%)29.2Z-Score
Enterprise Value $M2,562EPS $1.9Operating Margin %43.3F-Score7
P/E(ttm))11.1Cash Flow Per Share $2.7Pre-tax Margin (%)43.3Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %-0.9Quick Ratio0Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-5.9Current Ratio0Lower Leverage y-yY
Price/Cash Flow6.7y-y EBITDA Growth Rate %31.0ROA % (ttm)1.3Higher Current Ratio y-yN
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)10.4Less Shares Outstanding y-yY
Payout Ratio %23.0Shares Outstanding M66.6ROI % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with IBOC

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IBOCDavid Dreman 2013-09-30 Reduce-0.14%$21.33 - $25.24
($23.43)
$ 25.59%Reduce -71.78%92,829
IBOCDavid Dreman 2012-03-31 Add0.07%$18.47 - $21.79
($18.57)
$ 25.537%Add 57%406,090
IBOCDavid Dreman 2011-12-31 Buy 0.11%$12.49 - $19.31
($17.27)
$ 25.548%New holding, 258662 sh.258,662
IBOCDavid Dreman 2006-03-31 Sold Out -0.04%$28.14 - $29.22
($28.6)
$ 25.5-11%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBOC is held by these Gurus:

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK